Drug details
Rebinyn (coagulation factor ix (recombinant))
type of Hemostatics, Clotting Factors, Gene Therapy
Rebinyn (coagulation Factor IX (recombinant), GlycoPEGylated) is a recombinant DNA-derived coagulation Factor IX concentrate indicated for use in adults and children with hemophilia B for on-demand treatment and control of bleeding episodes, and perioperative management of bleeding.
This drug may have the following side effects:
- itching,
- injection site reactions, and
- hypersensitivity reactions.